LEGN, 5/20-5/23, -9.5% LOSS

٢٤ مايو ٢٠٢٤

Legend Biotech (LEGN) reported a loss of $0.16 per share on revenue of $93.99 million for the first quarter ended March 2024. The consensus estimate was a loss of $0.29 per share on revenue of $152.60 million. The company reported in-line with expectations while revenue grew 158.67% on a year-over-year basis.